{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:29:35Z","timestamp":1773224975127,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T00:00:00Z","timestamp":1403568000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1752-1947-8-223","type":"journal-article","created":{"date-parts":[[2014,6,24]],"date-time":"2014-06-24T09:07:35Z","timestamp":1403600855000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Insulin-induced localized lipoatrophy preceded by shingles (herpes zoster): a case report"],"prefix":"10.1186","volume":"8","author":[{"given":"Ernst A","family":"Chantelau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Pr\u00e4tor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Pr\u00e4tor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,24]]},"reference":[{"key":"2838_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.2337\/dc07-1739","volume":"31","author":"X Lopez","year":"2008","unstructured":"Lopez X, Castells M, Ricker A, Velazquez EF, Mun E, Goldfine AB: Human insulin analog-induced lipoatrophy. Diabetes Care. 2008, 31: 443-444.","journal-title":"Diabetes Care"},{"key":"2838_CR2","first-page":"417","volume":"21","author":"P Cabrera-Freitag","year":"2011","unstructured":"Cabrera-Freitag P, Escalada J, Goikoetxea MJ, Laguna S, Sanz ML, Gastaminza G: A severe case of lipoatrophy due to human insulin and insulin analogs in a patient with diabetes: is an immunological mechanism involved?. J Investig Allergol Clin Immunol. 2011, 21: 417-419.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"2838_CR3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5070\/D39GP7R8PR","volume":"12","author":"JA Aviles-Izquierdo","year":"2006","unstructured":"Aviles-Izquierdo JA, Longo-Imedio MI, Hernanz-Hermosa JM, Lazaro-Ochaita P: Bilateral localized lipoatrophy secondary to a single intramuscular corticosteroid injection. Dermatol Online J. 2006, 12: 17-","journal-title":"Dermatol Online J"},{"key":"2838_CR4","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1016\/j.diabres.2010.11.026","volume":"91","author":"D Peteiro-Gonz\u00e1lez","year":"2011","unstructured":"Peteiro-Gonz\u00e1lez D, Fern\u00e1ndez-Rodr\u00edguez B, Cabezas-Agr\u00edcola JM, Ara\u00fajo-Vilar D: Severe localized lipoatrophy related to therapy with insulin analogs in type 1a diabetes mellitus. Diabetes Res Clin Pract. 2011, 91: e61-e63.","journal-title":"Diabetes Res Clin Pract"},{"key":"2838_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-5996-3-33","volume":"3","author":"EA Chantelau","year":"2011","unstructured":"Chantelau EA, Pr\u00e4tor R, Pr\u00e4tor J, Poll LW: Relapsing insulin-induced lipoatrophy, cured by prolonged low-dose oral prednisone: a case report. Diabetol Metab Syndr. 2011, 3: 33-","journal-title":"Diabetol Metab Syndr"},{"key":"2838_CR6","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1210\/jc.2009-2773","volume":"95","author":"G Milan","year":"2010","unstructured":"Milan G, Murano I, Costa S, Pianta A, Tiengo C, Zulato E, Centobene C, Bruttomesso D, Cinti S, Vettor R: Lipoatrophy induced by subcutaneous insulin infusion. Ultrastructural analysis and gene expressing profiling. J Clin Endocrinol Metab. 2010, 95: 3126-3132.","journal-title":"J Clin Endocrinol Metab"},{"key":"2838_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0140-6736(09)60041-6","volume":"373","author":"T Nagase","year":"2009","unstructured":"Nagase T, Katsura Y, Iwaki Y, Nemoto K, Sekine H, Miwa K, Oh-I T, Kou K, Iwaya K, Noritake M, Matsuoka T: The insulin ball. Lancet. 2009, 373: 184-","journal-title":"Lancet"},{"key":"2838_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/adc.2010.183731","volume":"96","author":"A Babiker","year":"2011","unstructured":"Babiker A, Datta V: Lipoatrophy with insulin analogues in type 1 diabetes. Arch Dis Child. 2011, 96: 101-102.","journal-title":"Arch Dis Child"},{"key":"2838_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/EJE-09-0422","volume":"161","author":"P Touraine","year":"2009","unstructured":"Touraine P, D\u2019Souza GA, Kourides I, Abs R, Barclay P, Xie R, Pico A, Torres-Vela E, Ekman B, GH Lipoatrophy Study Group: Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH. Eur J Endocrinol. 2009, 161: 533-540.","journal-title":"Eur J Endocrinol"},{"key":"2838_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/j.1464-5491.2010.03196.x","volume":"28","author":"AN Tavare","year":"2011","unstructured":"Tavare AN, Doolittle HJ, Baburaj R: Case report. Pan-insulin allergy and severe lipoatrophy complicating type-2 diabetes. Diabet Med. 2011, 28: 500-503.","journal-title":"Diabet Med"},{"key":"2838_CR11","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1001\/jama.1976.03260340045021","volume":"235","author":"TH Whitley","year":"1976","unstructured":"Whitley TH, Lawrence PA, Smith CL: Amelioration of insulin lipoatrophy by dexamethasone injection. JAMA. 1976, 235: 839-840.","journal-title":"JAMA"},{"key":"2838_CR12","doi-asserted-by":"publisher","first-page":"926","DOI":"10.2337\/diacare.29.04.06.dc06-0004","volume":"29","author":"AJS Ramos","year":"2006","unstructured":"Ramos AJS, Farias MA: Human insulin-induced lipoatrophy. A successful treatment with glucocorticoid. Diabetes Care. 2006, 29: 926-927.","journal-title":"Diabetes Care"},{"key":"2838_CR13","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.2337\/dc11-2135","volume":"35","author":"HT Swelheim","year":"2012","unstructured":"Swelheim HT, Westerlaken C, Van Pinxteren-Nagler E, Bocca G: Lipoatrophy in a girl with type 1 diabetes: beneficial effects of treatment with a glucocorticoid added to an insulin analog. Diabetes Care. 2012, 35: e22-","journal-title":"Diabetes Care"},{"key":"2838_CR14","first-page":"742","volume":"76","author":"T Petruschke","year":"1993","unstructured":"Petruschke T, Hauner H: Tumor necrosis factor alpha prevents the differention of human adipocyte precursor cells and causes delipidation of newly developed fat cells. J Clin Endocrinol Metab. 1993, 76: 742-747.","journal-title":"J Clin Endocrinol Metab"},{"key":"2838_CR15","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1172\/JCI114345","volume":"84","author":"H Hauner","year":"1989","unstructured":"Hauner H, Entenmann G, Wabitsch M, Gaillard G, Ailhaud G, Negrel R, Pfeiffer EF: Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J Clin Invest. 1989, 84: 1663-1670.","journal-title":"J Clin Invest"},{"key":"2838_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00002018-199716010-00001","volume":"16","author":"M Levy","year":"1997","unstructured":"Levy M: Role of viral infections in the induction of adverse drug reactions. Drug Saf. 1997, 16: 1-8.","journal-title":"Drug Saf"},{"key":"2838_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2133\/dmpk.DMPK-10-RV-085","volume":"26","author":"X Zhang","year":"2011","unstructured":"Zhang X, Liu F, Chen X, Zhu X, Uetrecht J: Involvement of the immune system in idiosyncratic drug reactions. Drug Metab Pharmacokinet. 2011, 26: 47-59.","journal-title":"Drug Metab Pharmacokinet"},{"key":"2838_CR18","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1124\/pr.113.007450","volume":"65","author":"J Uetrecht","year":"2013","unstructured":"Uetrecht J, Naisbitt DJ: Idiosyncratic adverse drug reactions: current concepts. Pharmacol Rev. 2013, 65: 779-808.","journal-title":"Pharmacol Rev"},{"key":"2838_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1159\/000351708","volume":"79","author":"B Salgin","year":"2013","unstructured":"Salgin B, Meissner T, Beyer P, Haberland H, Borkenstein M, Fussenegger J, Brand U, Hauffa BP, Hungele A, Holl RW: Lipoatrophy is associated with an increased risk of Hashimoto\u2019s thyroiditis and coeliac disease in female patients with type 1 diabetes. Horm Res Paediatr. 2013, 79: 368-372.","journal-title":"Horm Res Paediatr"},{"key":"2838_CR20","first-page":"630","volume":"58","author":"PP Chakraborty","year":"2010","unstructured":"Chakraborty PP, Bhattacharjee R: Injection site lipoatrophy: a rare complication of recombinant human insulin. J Assoc Physicians India. 2010, 58: 630-","journal-title":"J Assoc Physicians India"},{"key":"2838_CR21","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1016\/j.diabres.2007.12.026","volume":"80","author":"MI Del Olmo","year":"2008","unstructured":"Del Olmo MI, Campos V, Abell\u00e1n P, Merino-Torres JF, Pi\u00f1\u00f3n F: A case of lipoatrophy with insulin detemir. Diabetes Res Clin Pract. 2008, 80: e20-e21.","journal-title":"Diabetes Res Clin Pract"},{"key":"2838_CR22","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.1016\/j.vaccine.2009.06.026","volume":"27","author":"S Ojaimi","year":"2009","unstructured":"Ojaimi S, Buttery JP, Korman TM: Quadrivalent Human Papillomavirus recombinant vaccine associated lipoatrophy. Vaccine. 2009, 27: 4876-4878.","journal-title":"Vaccine"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1752-1947-8-223\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1752-1947-8-223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T04:29:20Z","timestamp":1649478560000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/1752-1947-8-223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,24]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2838"],"URL":"https:\/\/doi.org\/10.1186\/1752-1947-8-223","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,24]]},"assertion":[{"value":"8 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"223"}}